# Daiichi Sankyo Chemical Pharma Co., Ltd. – FDA Inspection, Dec 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/56a2c626-2e61-41ea-b358-8e6ed18c4d79
Source feed: FDA_Inspections

> FDA inspection 1226353 of Daiichi Sankyo Chemical Pharma Co., Ltd., December 22, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226353
- Company Name: Daiichi Sankyo Chemical Pharma Co., Ltd.
- Inspection Date: 2023-12-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1080814 - 2019-01-18](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/0b7bde6c-6425-4ca6-a6c9-747e82f47a45)
- FDA Inspection 934436 - 2015-07-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)

Company: https://www.keypedia.com/companies/daiichi-sankyo-chemical-pharma-co-ltd/846f1b3f-281e-4616-ae05-902bf9bcb28c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
